Spotify Billionaire Launches Revolutionary Body Scan Startup in the U.S.

Neko Health is currently gaining significant attention for its advanced body scanning technology.
Co-founded by David Ek of Spotify and Hjalmar Nilsonne, Neko Health employs cutting-edge technology to monitor potential health issues in blood, skin, and metabolic functions. Originating in Sweden, the company has successfully raised nearly $1 billion and has recently made its debut in New York City, already amassing a global waitlist of over 300,000 individuals.
In an interview with a representative from Preface Ventures, Farooq Abbasi, who has invested in Neko Health, discussed his vision for the company as a pivotal player in preventative healthcare, particularly in the United States, where the medical system faces numerous challenges.
Abbasi pointed out that the adoption of preventative care is low in the U.S. primarily due to cost concerns. Currently, Neko Health charges $500 for a one-hour scan, which is not covered by insurance but may be eligible as an expense for those utilizing Health Savings Accounts. He emphasized, “I believe that preventative healthcare should be affordable and widely accessible.”
Neko Health aims to address these obstacles and is looking to expand further within the U.S. Abbasi shared his positive experiences after undergoing the scan twice, expressing his enthusiasm for the service. “I envision Neko clinics becoming ubiquitous,” he remarked.
He noted significant improvements in the product since his initial experience. “During my first scan, I received results for 15 biomarkers,” he explained. “This time, the scan evaluated 55.”
Using sophisticated computer vision for its assessments, Abbasi sees Neko Health as an example of how artificial intelligence is transforming the healthcare landscape. He believes this is more than just a trend; it offers individuals “actionable insights to enhance their well-being,” he stated.
Though Neko Health still faces challenges related to scaling and obtaining regulatory approvals in the U.S., Abbasi remains optimistic about the future. He anticipates increased investment in necessary innovations and believes that no systemic issues are insurmountable.



